Economic Consequences of Extending the Calving Intervals of Dairy Cows Treated With Recombinant Bovine Somatotropin

In response to a new recommendation that extending calving intervals to 18 months when dairy cows are treated with recombinant bovine somatotropin (rBST), an analysis was performed to see if the management practice was economically justified. This analysis was performed using a capital budgeting technique known as net present value analysis that accounts… CONTINUE READING